Past Projects

Principal Investigators: Assoc Prof. Giorgia Pastorin
Team members: Goh Wei Jiang, Shui Zou

EXOPLEX is a novel drug delivery system of nanoscale dimensions with features of improved cellular uptake, cell targeting and low toxicity, as well as the ability for further functionalisation. Currently we are using EXOPLEXs to transfect or introduce genetic material into difficult-to-transfect cell lines and evaluating its commercial viability as a research reagent. EXOPLEXs would be a one-step transfection reagent with the aim of improved transfection efficiency compared to conventional non-viral transfection methods.

Principal Investigators: Assoc Prof. Huang Dejian
Team members: Liang Dong, Katja Krizman, Ivan Zwe, See Xin Yi, Jun Matsumoto

Garlic supplements are known for their health promoting effects, especially cardiovascular protection. This is achieved through the generation of Hydrogen Sulfide (H2S), a gasotransmitter from garlic polysulfide. However, conventional polysulfides release H2S instantly within the human body, while slow-releasing H2S donor is preferred for longer lasting effects; they also have a strong garlic smell. We have developed a method to make a compound which is safe, water soluble, free of garlic smell, and more importantly, is able to generate H2S slowly.

Team members: Dr. Ajith Isaac, Dr. Gary Ang, Dr. Shawn Gao, Samarth Bhargava

We are developing a biomedical device to be used in colorectal surgery to reduce the risk of leakage from the intestine (anastomotic leakage). Based on our pilot experiments, our proposed solution to this problem is comprised of a novel sealant and propriety delivery device that can be easily adopted into the current surgical workflow. The sealant will be delivered at the site of the anastomosis as a prophylactic to reduce leak rates.

Principal Investigators: Prof. Zhang Yong
Team members: Dr. Muthu Kumara, Akshaya Bansal, Chris Ho Jun Hui

Upconversion nanoparticles are a unique range of fluorescent nanoparticles. These nanoparticles act as a platform technology and can be used in a variety of applications such as imaging, food testing, environmental testing, veterinary testing, in-vitro diagnostics, anti-counterfeiting, optogenetics and cancer therapy.

Principal Investigators: Assoc Prof. Heng Chun Huat
Team members: David Wong, Yu Ju Feng, Siddharth Manoharan

We have designed a light-weight integrated wearable medical grade wireless vital signs patch for continuous acquisition of vital signs such as temperature, respiration, 3 lead-ECG, pulse oximeter and blood pressure to allow clinicians to have continuous healthcare surveillance on their patients. It is also supported by a cloud-based client application, that displays, records and analyses (trending and alerts) real-time vital stats to assist clinicians in providing better clinical care. This solution can also be realised in private clinics, home-care, community and rural healthcare monitoring.

Principal Investigators: Assoc Prof. Caroline Lee
Team members: Dr. Maulana Bachtiar, Tony Sugiarta, Theodora Chung, Dr. Ang Siang Yun

A new algorithm to predict drugs which may display population differences in response through the interrogation of the human genome and drug response pathways. The robustness of this strategy is evident from the accurate prediction of 10 of 11 drugs which were previously reported to show population differences in response. A high proportion of drugs with pharmacogenetics warning-labels are also predicted to show population differences in response.